- Pfizer’s shares are plunging downwards to their worst performance in over a decade after the pharmaceutical giant put out a stark warning about its projected revenue as hysteria over the Covid-19 outbreak continues to wane.
- Recent financial results and projections alike have not fared well for Pfizer; shares dropped 8 percent on Thursday morning, and the company has lost $140 billion in market cap this year alone.
- Pfizer projects that revenue could fall next year and has put out a 2024 guidance that is below analyst expectations, according to a new report by The Wall Street Journal.
Trending
That’s A Shame: Pfizer Has Lost $140B In Market Cap As People Reject Boosters
Pfizer CEO Albert Bourla speaks during a ceremony in the northern city of Thessaloniki, Tuesday, Oct. 12, 2021. Pfizer inaugurated the company's new centers for Digital Innovation and Business Operations and Services in the second largest city of the country. (AP Photo/Giannis Papanikos)
